phosphocreatine and Inflammation

phosphocreatine has been researched along with Inflammation* in 7 studies

Reviews

1 review(s) available for phosphocreatine and Inflammation

ArticleYear
Inflammation in acute coronary syndromes.
    Haematologica, 2001, Volume: 86, Issue:11 Suppl 2

    Topics: Acute Disease; Coronary Artery Disease; Cytokines; Humans; Inflammation; Myocardial Ischemia; Phosphocreatine

2001

Trials

1 trial(s) available for phosphocreatine and Inflammation

ArticleYear
Protection of Exogenous Phosphocreatine for Myocardium in Percutaneous Coronary Intervention Related to Inflammation.
    Reviews in cardiovascular medicine, 2022, Mar-09, Volume: 23, Issue:3

    Although injury of myocardium after percutaneous coronary intervention (PCI) has been reported, the mechanism and effect of exogenous phosphocreatine (PCr) supplementation on the injury are yet to be elucidated. Biomarkers, such as interleukin-6 (IL-6) and variations in white blood cells for inflammation, and serum cardiac troponin I (cTnI) for myocardial injury are examined.. A total of 105 patients undergoing PCI were included and randomly divided into two groups: control (treated with routine hydration therapy) and PCr (treated with additional intravenous infusion of exogenous PCr). The serum levels of biomarkers were detected at administration and 4, 12, 24, and 48 h after PCI, with natural logarithmic (loge) transformation of data when modeling assumptions were not fulfilled.. The level of loge-transformed IL-6 increased in both groups, especially at 12 and 24 h after the operation, and that of PCr group was less than the control group at 48 h. The content of loge-transformed cTnI was significantly increased in both groups, while that of the PCr group was markedly lower than the control group at all time points after PCI. Moreover, the ratio of neutrophils was elevated at all time points after PCI, while that of the PCr group was lower at 48 h, and the variations in the ratio of lymphocytes showed opposite results.. Exogenous phosphocreatine reduces stent implantation, triggers inflammation manifested as decreased serum levels of IL-6 and the aggregation of neutrophils, and protects the myocardium of the patients undergoing PCI. These findings provided the potential mechanism and treatment for myocardial injury associated with PCI.

    Topics: Biomarkers; Humans; Inflammation; Interleukin-6; Myocardium; Percutaneous Coronary Intervention; Phosphocreatine; Troponin I

2022

Other Studies

5 other study(ies) available for phosphocreatine and Inflammation

ArticleYear
Impaired phosphocreatine metabolism in white adipocytes promotes inflammation.
    Nature metabolism, 2022, Volume: 4, Issue:2

    The mechanisms promoting disturbed white adipocyte function in obesity remain largely unclear. Herein, we integrate white adipose tissue (WAT) metabolomic and transcriptomic data from clinical cohorts and find that the WAT phosphocreatine/creatine ratio is increased and creatine kinase-B expression and activity is decreased in the obese state. In human in vitro and murine in vivo models, we demonstrate that decreased phosphocreatine metabolism in white adipocytes alters adenosine monophosphate-activated protein kinase activity via effects on adenosine triphosphate/adenosine diphosphate levels, independently of WAT beigeing. This disturbance promotes a pro-inflammatory profile characterized, in part, by increased chemokine (C-C motif) ligand 2 (CCL2) production. These data suggest that the phosphocreatine/creatine system links cellular energy shuttling with pro-inflammatory responses in human and murine white adipocytes. Our findings provide unexpected perspectives on the mechanisms driving WAT inflammation in obesity and may present avenues to target adipocyte dysfunction.

    Topics: Adipocytes, White; Animals; Creatine; Humans; Inflammation; Mice; Obesity; Phosphocreatine

2022
A role for phosphocreatine in adipose inflammation.
    Nature reviews. Endocrinology, 2022, Volume: 18, Issue:5

    Topics: Adipose Tissue; Energy Metabolism; Humans; Inflammation; Phosphocreatine

2022
Hydrogen-Rich Saline Attenuates Lipopolysaccharide-Induced Heart Dysfunction by Restoring Fatty Acid Oxidation in Rats by Mitigating C-Jun N-Terminal Kinase Activation.
    Shock (Augusta, Ga.), 2015, Volume: 44, Issue:6

    Sepsis is common in intensive care units (ICU) and is associated with high mortality. Cardiac dysfunction complicating sepsis is one of the most important causes of this mortality. This dysfunction is due to myocardial inflammation and reduced production of energy by the heart. A number of studies have shown that hydrogen-rich saline (HRS) has a beneficial effect on sepsis. Therefore, we tested whether HRS prevents cardiac dysfunction by increasing cardiac energy. Four groups of rats received intraperitoneal injections of one of the following solutions: normal saline (NS), HRS, lipopolysaccharide (LPS), and LPS plus HRS. Cardiac function was measured by echocardiography 8 h after the injections. Gene and protein expression related to fatty acid oxidation (FAO) were measured by quantitative polymerase chain reaction (PCR) and Western blot analysis. The injection of LPS compromised heart function through decreased fractional shortening (FS) and increased left ventricular diameter (LVD). The addition of HRS increased FS, palmitate triphosphate, and the ratio of phosphocreatinine (PCr) to adenosine triphosphate (ATP) as well as decreasing LVD. The LPS challenge reduced the expression of genes related to FAO, including perioxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), perioxisome proliferator-activated receptor alpha (PPARα), Estrogen-related receptor alpha (ERRα), and their downstream targets, in mRNA and protein level, which were attenuated by HRS. However, HRS had little effect on glucose metabolism. Furthermore, HRS inhibited c-Jun N-terminal kinase (JNK) activation in the rat heart. Inhibition of JNK by HRS showed beneficial effects on LPS-challenged rats, at least in part, by restoring cardiac FAO.

    Topics: Adenosine Triphosphate; Animals; Echocardiography; Fatty Acids; Heart; Heart Diseases; Heart Ventricles; Hydrogen; Inflammation; Injections, Intraperitoneal; Intensive Care Units; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Male; Myocardium; Oxygen; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphocreatine; Polymerase Chain Reaction; PPAR alpha; Rats; Rats, Sprague-Dawley; Sepsis; Sodium Chloride; Transcription Factors

2015
Foot muscle energy reserves in diabetic patients without and with clinical peripheral neuropathy.
    Diabetes care, 2009, Volume: 32, Issue:8

    OBJECTIVE To investigate changes in the foot muscle energy reserves in diabetic non-neuropathic and neuropathic patients. RESEARCH DESIGN AND METHODS We measured the phosphocreatinine (PCr)/inorganic phosphate (Pi) ratio, total (31)P concentration, and the lipid/water ratio in the muscles in the metatarsal head region using MRI spectroscopy in healthy control subjects and non-neuropathic and neuropathic diabetic patients. RESULTS The PCr/Pi ratio was higher in the control subjects (3.23 +/- 0.43) followed by the non-neuropathic group (2.61 +/- 0.36), whereas it was lowest in the neuropathic group (0.60 +/- 1.02) (P < 0.0001). There were no differences in total (31)P concentration and lipid/water ratio between the control and non-neuropathic groups, but both measurements were different in the neuropathic group (P < 0.0001). CONCLUSIONS Resting foot muscle energy reserves are affected before the development of peripheral diabetic neuropathy and are associated with the endothelial dysfunction and inflammation.

    Topics: Diabetes Mellitus; Diabetic Neuropathies; Endothelium, Vascular; Energy Metabolism; Female; Foot; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Phosphates; Phosphocreatine; Reference Values

2009
Anti-inflammatory activity of creatine supplementation in endothelial cells in vitro.
    British journal of pharmacology, 2003, Volume: 139, Issue:4

    1 Creatine (CR) supplementation augments muscle strength in skeletal muscle cells by increasing intracellular energy pools. However, the effect of CR supplementation on endothelial cells remains to be clarified. 2 In this study, we investigated whether CR supplementation had any anti-inflammatory activity against human pulmonary endothelial cells in culture. 3 We confirmed that supplementation with 0.5 mM CR significantly increased both intracellular CR and phosphocreatine (PC) through a CR transporter while keeping intracellular ATP levels constant independent of CR supplementation and a CR transporter antagonist. 4 In the assay system of endothelial permeability, supplementation with 5 mM CR significantly suppressed the endothelial permeability induced by serotonin and H(2)O(2). 5 In cell adhesion experiments, supplementation with 5 mM CR significantly suppressed neutrophil adhesion to endothelial cells. 6 In the measurement of adhesion molecules, CR supplementation with more than 0.5 mM CR significantly inhibited the expressions of ICAM-1 and E-selectin on endothelial cells, and the inhibition was significantly suppressed by an adenosine A(2A) receptor antagonist. 7 The present study suggests that CR supplementation has anti-inflammatory activities against endothelial cells.

    Topics: Adenosine Triphosphate; Anti-Inflammatory Agents; Cell Adhesion; Cells, Cultured; Creatine; Dietary Supplements; E-Selectin; Endothelium, Vascular; Guanidines; Humans; Hydrogen Peroxide; Inflammation; Intercellular Adhesion Molecule-1; Intracellular Membranes; Lung; Neutrophil Activation; Neutrophils; Permeability; Phosphocreatine; Propionates; Serotonin; Tumor Necrosis Factor-alpha

2003